TNF and colitis: The cPLA2 inhibitor pyrrophenone ameliorated colitis in terms of DAI (Figure 4C), histological inflammation (Figure 4D), and score (Figure 4E), colon length (Figure 4F), and the colonic levels of TNF-α (Figure 4G) and LTB4 (Figure 4H).